Dougal Adamson joined M Ventures in March 2019 as an analyst in the Life Sciences team. Previously, he gained experience in the healthcare industry across roles in consulting, corporate strategy, business intelligence and finance. This included time as an in-house consultant at Novo Nordisk, a global pharmaceutical firm, where he worked on long-term investment strategies. Dougal received an MPhil in Bioscience Enterprise from the University of Cambridge and a BSc in Biochemistry from the University of St Andrews. During his MPhil, Dougal completed a market entry analysis on a novel therapeutic area on behalf of a leading UK biotechnology company. Dougal is based in Amsterdam.